FOLEY HOAG LLP for CUBIST PHARMACEUTICALS
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Affordable Care Act of 2010 (Pub. L. 111-148) Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the Food and Drug Administration Safety and Innovation Act(FDASIA) Pub.L. 112-144) H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 H.R. 3742, Antibiotic Development to Advance Patient Treatment (ADAPT) Act H.R. 4187, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act House Committee on Energy & Commerce 21st Century Cures initiative.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.